125 related articles for article (PubMed ID: 2589363)
1. Safety and efficacy of intravenous ciprofloxacin in the treatment of selected infections.
Abadie-Kemmerly S; Pankey GA
Am J Med; 1989 Nov; 87(5A):213S-220S. PubMed ID: 2589363
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
[TBL] [Abstract][Full Text] [Related]
3. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
Modai J
Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
Peacock JE; Pegram PS; Weber SF; Leone PA
Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
[TBL] [Abstract][Full Text] [Related]
5. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
6. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
Fass RJ; Plouffe JF; Russell JA
Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
Quintero-Perez NP; Andrade-Villaneuva JF; Leon-Garnica G; Bertin-Montano M; Rodriguez-Chagollan JJ; Rodriguez-Noriega E
Am J Med; 1989 Nov; 87(5A):198S-201S. PubMed ID: 2686424
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
Villavicencio J; Asensio de Fernandez ME; Ramirez CA
Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
[TBL] [Abstract][Full Text] [Related]
9. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
Sifuentes-Osornio J; MacĂas A; Amieva RI; Ramos A; Ruiz-Palacios GM
Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
[TBL] [Abstract][Full Text] [Related]
10. Intravenous ciprofloxacin therapy in severe infections.
Gudiol F; Cabellos C; Pallares R; Linares J; Ariza J
Am J Med; 1989 Nov; 87(5A):221S-224S. PubMed ID: 2589364
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
Levine DP; McNeil P; Lerner SA
Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
[TBL] [Abstract][Full Text] [Related]
12. Treatment of serious infections with intravenous ciprofloxacin.
Scully BE; Neu HC
Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
[TBL] [Abstract][Full Text] [Related]
13. Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.
Neu HC; Davidson S; Briones F
Am J Med; 1989 Nov; 87(5A):209S-212S. PubMed ID: 2511758
[TBL] [Abstract][Full Text] [Related]
14. Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin.
Brown AE; Smith G
Am J Med; 1989 Nov; 87(5A):266S-268S. PubMed ID: 2589376
[TBL] [Abstract][Full Text] [Related]
15. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
Gaut PL; Carron WC; Ching WT; Meyer RD
Am J Med; 1989 Nov; 87(5A):169S-175S. PubMed ID: 2686417
[TBL] [Abstract][Full Text] [Related]
16. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
Davis C
Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
Parish LC; Asper R
Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
[TBL] [Abstract][Full Text] [Related]
18. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
[TBL] [Abstract][Full Text] [Related]
19. Safety of intravenous ciprofloxacin. A review.
Arcieri GM; Becker N; Esposito B; Griffith E; Heyd A; Neumann C; O'Brien B; Schacht P
Am J Med; 1989 Nov; 87(5A):92S-97S. PubMed ID: 2686431
[TBL] [Abstract][Full Text] [Related]
20. A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Screen P; Becker N; August R
J Clin Pharmacol; 1988 Feb; 28(2):179-89. PubMed ID: 3360968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]